Autophagy as a therapeutic target in pancreatic cancer.
Autophagy as a therapeutic target in pancreatic cancer.
复制标题
DOI:
10.1038/s41416-020-01039-5
复制
发表时间:
2021-01
影响因子:
8.8
通讯作者:
Cassier PA
中科院分区:
文献类型:
--
作者:
Piffoux M;Eriau E;Cassier PA
Pancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis and resistance to anti-cancer therapy, leading to an overall poor prognosis. Despite continued research efforts, no targeted therapy has yet shown meaningful efficacy in PDAC; mutations in the oncogene KRAS and the tumour suppressor TP53, which are the most common genomic alterations in PDAC, have so far shown poor clinical actionability. Autophagy, a conserved process allowing cells to recycle altered or unused organelles and cellular components, has been shown to be upregulated in PDAC and is implicated in resistance to both cytotoxic chemotherapy and targeted therapy. Autophagy is thus regarded as a potential therapeutic target in PDAC and other cancers. Although the molecular mechanisms of autophagy activation in PDAC are only beginning to emerge, several groups have reported interesting results when combining inhibitors of the extracellular-signal-regulated kinase/mitogen-activated protein kinase pathway and inhibitors of autophagy in models of PDAC and other KRAS-driven cancers. In this article, we review the existing preclinical data regarding the role of autophagy in PDAC, as well as results of relevant clinical trials with agents that modulate autophagy in this cancer.
登录
查看更多内容
影响因子:
3.4
作者:
Dorn GW 2nd
通讯作者:
Dorn GW 2nd
影响因子:
0.4
作者:
Chen, Hung-En;Lin, Ji-Fan;Hwang, I-Sheng Thomas
通讯作者:
Hwang, I-Sheng Thomas
影响因子:
21.3
作者:
Dowdle, William E.;Nyfeler, Beat;Murphy, Leon O.
通讯作者:
Murphy, Leon O.
影响因子:
3.3
作者:
Fujita, Naonobu;Hayashi-Nishino, Mitsuko;Yoshimori, Tamotsu
通讯作者:
Yoshimori, Tamotsu
影响因子:
3.4
作者:
Brun, Sonia;Bassissi, Firas;Halfon, Philipe
通讯作者:
Halfon, Philipe